AEDG comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-24. Numbers and descriptions here follow the published literature rather than marketing material.
Published evidence comes mainly from Russian-language journals and from a single research group, with small sample sizes and limited independent replication. A few laboratories outside that group have examined related peptides and reported weaker or absent telomerase effects, so the central claim is best described as contested rather than settled. Rodent studies report modest changes in some ageing markers and in survival, but designs vary and control conditions are often sparse. No large randomised trial in humans has been published, and long-term safety data in healthy populations are correspondingly thin.
Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. It was designed at the St. Petersburg Institute of Bioregulation and Gerontology as a short, chemically defined analogue of epithalamin, a fraction obtained from bovine pineal tissue. Small peptide bioregulators of this type formed a long-running line of work there from the 1980s onward. Because the molecule is produced by solid-phase synthesis rather than extraction, its composition is exact and its purity can be measured directly.
The peptide emerged from research carried out in Saint Petersburg from the late 1980s onward, where investigators searched for shorter active fragments of a pineal preparation known as epithalamin. The name epitalon was chosen to reflect that parent extract. Early reports described effects on neuroendocrine markers and on the lifespan of laboratory animals. Much of that work appeared in Russian-language journals, with English translations following later, which affects how readily the original protocols can be assessed by outside groups.
Published studies on epitalon are dominated by a small number of research groups, and independent replication in other laboratories remains limited. Proposed mechanisms include activation of telomerase and modulation of melatonin rhythms, but the evidence for either rests mainly on cell cultures and animal models. Whether the peptide produces comparable effects in humans is an open question, and the absence of large controlled trials means the literature is best read as exploratory rather than settled.
Epitalon is a synthetic four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9, and its calculated molar mass is approximately 390.35 grams per mole. The compound is a short fragment related to a peptide fraction isolated from bovine pineal gland extracts, and it is normally supplied as a lyophilised powder intended for laboratory research. It is not a registered pharmaceutical product in most countries.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C14H22N4O9 | Calculated from the four residues with three water losses |
| Molecular mass | About 390.35 g/mol | Monoisotopic mass near 390.14, used for mass-spectrometric identification |
| Peptide sequence | Ala-Glu-Asp-Gly | Single-letter form AEDG; no disulfide bonds or modified residues |
| Appearance | White to off-white solid | Supplied as a dried powder |
| Isoelectric point | Around 4 | Estimated from aspartate and glutamate side-chain pKa values |
Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.
Epitalon is a synthetic tetrapeptide whose sequence is alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. It was developed in Russia during the 1980s and 1990s by investigators associated with the St. Petersburg Institute of Bioregulation and Gerontology, who studied short peptides as regulators of gene expression and tissue function. The alternative spelling epithalon appears interchangeably in the literature, and the two names refer to the same molecule. Outside Russia it is encountered chiefly as a research chemical rather than a licensed medicine, and it holds no approval from the United States Food and Drug Administration or the European Medicines Agency.
Proposed mechanisms centre on cell-culture observations rather than a defined receptor interaction. Several reports describe increased expression of the telomerase catalytic subunit after exposure of cultured human cells, and the authors attributed the effect to short peptide fragments entering the nucleus and influencing gene transcription. No receptor for the tetrapeptide has been identified, and the free peptide is expected to be degraded rapidly by plasma peptidases. Whether any measurable fraction reaches intact tissues after administration remains an unresolved question rather than an established finding.
The published literature is dominated by a small number of research groups, much of it in Russian-language journals, and independent replication outside those groups is limited. Studies are typically small, use cultured cells or rodent models, and report endpoints that differ between papers, which makes comparison difficult. Large randomised human trials have not appeared in the indexed literature. Questions about absorption, distribution and clearance are therefore still treated as open in reviews that mention the compound.
（TG:@pojiaai）Epitalon is a synthetic linear tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, abbreviated AEDG. It emerged from work on epithalamin, a peptide fraction prepared from bovine pineal tissue, and was designed as a short, chemically defined analogue of that extract. Early publications came mainly from Russian laboratories studying pineal peptides and aging-related endpoints. The compound appears in the literature under several spellings, including epithalon and epithalone, which complicates systematic searching. Its small size makes solid-phase assembly and routine analytical characterization straightforward.
Chemically, the molecule consists of four amino acid residues joined by three peptide bonds, with a free N-terminal amino group and a free C-terminal carboxyl group. Its molecular formula is C14H22N4O9, and its monoisotopic mass is approximately 390 daltons. The acidic glutamate and aspartate side chains give the peptide a net negative charge near neutral pH, a property that shapes its chromatographic behaviour and solubility profile. No disulfide bridges or other post-translational modifications are present, so the primary sequence alone defines the structure.
The word vulva is Latin for "womb". It derives from the 1540s in referring to the womb and female sexual organs, from the earlier volvere meaning to turn, roll or revolve, with further derivatives such as used in volvox, and volvulus (twisted bowel). The naming of the female (and male) genitals as pudenda membra, meaning parts to be ashamed of, dates from the mid-17th century. The naming influenced the general perception of the vulva and this is shown in depicted gynaecological procedures. The examiner shown in the Obstetrical examination dated 1822, is adopting the compromise procedure where the woman's genitals cannot be seen.
"Victims as Defenders: African Troops in the Rhodesian Defence System 1890–1980". Small Wars & Insurgencies. 2 (2): 240–275. doi:10.1080/09592319108422981. Molomo, Mpho G. (2009). "The Link between Sustainable Development and Security in Botswana". In Cawthra, Gavin (ed.). African Security Governance: Emerging Issues. Tokyo: United Nations University Press. pp. 131–156. ISBN 9789280811773. Melson, C. D. (2005). "Top Secret War: Rhodesian Special Operations". Small Wars and Insurgencies. 16 (1): 57–82. doi:10.1080/0959231042000322567. S2CID 145455177. Moorcraft, Paul L.; McLaughlin, Peter (1982). Chimurenga! The War in Rhodesia, 1965-1980. A Military history. Marshalltown, South Africa: Sygma/Collins. ISBN 0620062142. Moorcraft, P. L.; McLaughlin, P. (2010). The Rhodesian War: A Military History. Stackpole Books. ISBN 9780811707251. Morse, Stephen A. (2006). "Historical Perspectives of Microbial Bioterrorism". In Anderson, Burt; Friedman, Herman; Bendinelli, Mauro (eds.). Microorganisms and Bioterrorism. New York City: Springer. pp. 15–30. ISBN 9780387281568. O'Brien, Kevin (September 2001). "Counter-Intelligence for counter-revolutionary warfare: The South African police security branch 1979–1990". Intelligence and National Security. 16 (3): 27–59. doi:10.1080/02684520412331306200. S2CID 153561623. Palmer, Robin (October 1983). "Review: From Zimbabwe to Azania? A Review Article". African Affairs. 82 (329): 574–578. doi:10.1093/oxfordjournals.afraf.a097565. JSTOR 721219. Prokosh, Eric, ed. (1994). "Disappearances" and Political Killings: Human Rights Crisis of the 1990s.
=== Acidity/basicity === Ionic compounds containing hydrogen ions (H+) are classified as acids, and those containing electropositive cations and basic anions ions hydroxide (OH−) or oxide (O2−) are classified as bases. Other ionic compounds are known as salts and can be formed by acid–base reactions. Salts that produce hydroxide ions when dissolved in water are called alkali salts, and salts that produce hydrogen ions when dissolved in water are called acid salts, e.g. sodium hydrogen selenite (NaHSeO3). If the compound is the result of a reaction between a strong acid and a weak base, the result is an acid salt. If it is the result of a reaction between a strong base and a weak acid, the result is a base salt. If it is the result of a reaction between a strong acid and a strong base, the result is a neutral salt. Weak acids reacted with weak bases can produce ionic compounds with both the conjugate base ion and conjugate acid ion, such as ammonium acetate. Some ions are classed as amphoteric, being able to react with either an acid or a base. This is also true of some compounds with ionic character, typically oxides or hydroxides of less-electropositive metals (so the compound also has significant covalent character), such as zinc oxide, aluminium hydroxide, aluminium oxide and lead(II) oxide.
=== CNS === Axons that react to URP are primarily found in organum vasculosum laminae terminalis (OVLT) and in the median eminence (ME). These axons are located near the hypothalamus and almost always contain the hormone Gondotropin- releasing hormone (GnRH) which was found through in situ hybridization which provides information of the anatomical location URP mRNA. This means that URP might have an effect on reproduction which has not been discovered .
Sources: en.wikipedia.org
==== Absorption ==== Pseudoephedrine is orally active and is readily absorbed from the gastrointestinal tract. Its oral bioavailability is approximately 100%. The drug reaches peak concentrations after 1 to 4 hours (mean 1.9 hours) in the case of the immediate-release formulation and after 2 to 6 hours in the case of the extended-release formulation. The onset of action of pseudoephedrine is 30 minutes.
=== Cases of poisoning === Despite the element's highly hazardous properties, circumstances in which polonium poisoning can occur are rare. Its extreme scarcity in nature, the short half-lives of all its isotopes, the specialised facilities and equipment needed to obtain any significant quantity, and safety precautions against laboratory accidents all make harmful exposure events unlikely. As such, only a handful of cases of radiation poisoning specifically attributable to polonium exposure have been confirmed.
== Research == His research proposed that peptide hormones are produced from large precursor proteins. In 1967, Chrétien first articulated the prohormone theory, proposing that peptide hormones are produced from larger precursors, a paradigm later widely confirmed and foundational for modern endocrinology. In 1976, his team discovered human β-endorphin, advancing understanding of endogenous opioid systems in pain and stress biology. In 1990, Chrétien and collaborators identified the family of proprotein convertases (PCs/PCSK1–9), endoproteases that activate many precursor proteins and hormones, helping to establish a field often termed “functional endoproteolysis.” A loss-of-function PCSK9 variant characterized in French-Canadian families by Chrétien’s group is associated with markedly low LDL cholesterol and cardioprotection, work that helped validate PCSK9 as a therapeutic target. Chrétien’s prohormone/convertase research has had broad clinical impact, informing therapies and biological understanding in diabetes, obesity, dyslipidemia, atherosclerosis, cancer, opiate use disorders, and Alzheimer’s disease. Between 1981 and 1990, he ranked among the world’s most-cited scientists (reported as seventh globally) reflecting the reach of his contributions.
== Bibliography == Antoni Czubiński, Powstanie Wielkopolskie 1918–1919. Geneza-charakter-znaczenie, Poznań 1978 Antoni Czubiński, Rola Powstania Wielkopolskiego w walce narodu polskiego o powstrzymanie niemieckiego >parcia na wschód<, Przegląd Zachodni 1968, nr 5–6 A. Czubiński, Z.Grot, B.Miśkiiewcz, Powstanie Wielkopolskie 1918–1919. Zarys dziejów, Warszawa 1978 K. Dembski, Wielkopolska w początkach II Rzeczypospolitej. Zagadnienia prawno-ustrojowe, Poznań 1972 Roman Dmowski, Polityka polska i odbudowanie państwa 1925 Z. Grot (ed.), Powstanie wielkopolskie 1918–1919, Poznań 1968 Z. Grot, I. Pawłowski, M. Pirko, Wielkopolska w walce o niepodległość 1918–1919. Wojskowe i polityczne aspekty Powstania Wielkopolskiego, Warszawa 1968 P. Hauser, Niemcy wobec sprawy polskiej X 1918–VI 1919, Poznań 1984 K. Kandziora, Działalność POW w Poznaniu. Przyczynek do historii Polskiej Organizacji Wojskowej zaboru pruskiego w latach 1918–1919, Warszawa 1939 S. Kubiak, Niemcy a Wielkopolska 1918–1919, Poznań 1969 Joseph Lamia: Der Aufstand in Posen (The Uprising in Poznan). Berlin 1919 (in German). Materiały Sesji Naukowej z okazji 50-lecia Powstania Wielkopolskiego 1918/1919, Zaszyty Naukowe UAM 1970, Historia t.10 Witold Mazurczak, Anglicy i wybuch powstania wielkopolskiego. Z dziejów genezy brytyjskiej misji płka H.H.Wade'a w Polsce, [in:] Antoni Czubiński (ed.), Polacy i Niemcy. Dziesięć wieków sąsiedztwa, PWN, Warszawa 1987 Janusz Pajewski, Rodział XXII.
=== For Alzheimer's disease === Several companies are in the early stages of development and testing of this potential class of treatment. In March 2008 phase I results were reported for CoMentis Inc's candidate CTS-21166. In April 2012 Merck & Co., Inc reported phase I results for its candidate verubecestat (MK-8931). Merck began a Phase II/III trial of MK-8931 in December, 2012 estimated to be completed in July 2019. In February 2017, Merck halted its late-stage trial of verubecestat for mild to moderate Alzheimer's disease after it was reported as having "virtually no chance" of working according to an independent panel of experts. This came just three months after Eli Lilly & Co. announced its own setback with solanezumab. In September 2014 AstraZeneca and Eli Lilly and Company announced an agreement to codevelop lanabecestat (AZD3293). A pivotal Phase II/III clinical trial of lanabecestat started in late 2014, but was halted in 2018 before its planned conclusion due to poor results. Another BACE1 inhibitor that has reached phase II trials is the Eli Lilly's inhibitor LY2886721. The data on phase I trial were first presented at the Alzheimer's Association International conference in 2012. Daily dosing during 2 weeks, reduced BACE1 activity by 50–75% and CSF Aβ42 by 72% (Willis et al., 2012; Bowman Rogers and Strobel, 2013). Recently, Lilly reported that the phase II trial of LY2886721 was terminated due to liver abnormalities that were found in 4 out of 45 patients (Rogers, 2013).
Sources: en.wikipedia.org
In December 2022, the British government announced that it planned to open the Independent Inquiry relating to Afghanistan to investigate extrajudicial killings that took place between 2010 and 2013, during the War in Afghanistan. This followed a detailed BBC Panorama investigation that found members of the SAS "repeatedly killed detainees and unarmed men in suspicious circumstances". Panorama spoke to witnesses who alleged that operatives justified the killings of unarmed persons by leaving weapons at the scenes of the shootings and that SAS squadrons competed '"with each other to get the most kills". According to the investigation, officers of the UK Special Forces were concerned over the number of reports of detainees being killed after reaching for hidden weapons. Allegedly, several raids ended with the deaths of more people than weapons recovered. The BBC visited the sites of some raids and heard from ballistics experts who interpreted the bullet patterns present as more indicative "of execution-style killings rather than firefights". A formal internal review was opened at the time, but evidence was never passed to military police. The inquiry was launched in March 2023, to be chaired by Lord Justice Haddon-Cave. In September 2024, an internal Ministry of Defence document written in 2019 was presented to the inquiry that concluded that the BBC Panorama allegations were "broadly accurate".
== Structure == Bacterial glutathione transferases of all classes are homodimeric enzymes (although heterodimeric isozymes of certain classes are also known). Monomers fold into a two-domain configuration to form the active enzyme structure. These globular proteins have an N-terminal domain that consists of a mixture of alpha-helices and beta strands, while the C-terminal domain is all-helical. The N-terminal domain contains the glutathione-binding site and is a highly conserved region among all GSTs. This domain has a similar composition to thioredoxins, which act as antioxidants by facilitating the reduction of other proteins. In comparison, the region that contains the greatest amount of variability between GST classes is contained in the alpha-2 helix on the C-terminal domain. The predominantly alpha-helical C-terminal domain is involved with the binding of hydrophobic substrates (such as hydrophobic portions of xenobiotics). The specificity of the alpha-2 helix stems from the assortment of amino acids in the domain that interacts with the glycine residue of glutathione.
It is rare to find less than five interacting parallel strands in a motif, suggesting that a smaller number of strands may be unstable, however it is also fundamentally more difficult for parallel β-sheets to form because strands with N and C termini aligned necessarily must be very distant in sequence . There is also evidence that parallel β-sheet may be more stable since small amyloidogenic sequences appear to generally aggregate into β-sheet fibrils composed of primarily parallel β-sheet strands, where one would expect anti-parallel fibrils if anti-parallel were more stable. In parallel β-sheet structure, if two atoms Cαi and Cαj are adjacent in two hydrogen-bonded β-strands, then they do not hydrogen bond to each other; rather, one residue forms hydrogen bonds to the residues that flank the other (but not vice versa). For example, residue i may form hydrogen bonds to residues j − 1 and j + 1; this is known as a wide pair of hydrogen bonds. By contrast, residue j may hydrogen-bond to different residues altogether, or to none at all. The hydrogen bond arrangement in parallel beta sheet resembles that in an amide ring motif with 11 atoms. Finally, an individual strand may exhibit a mixed bonding pattern, with a parallel strand on one side and an antiparallel strand on the other.
=== RNA editing and the genome === Octopuses, like other coleoid cephalopods but unlike more basal cephalopods or other molluscs, are capable of greater RNA editing, changing the nucleic acid sequence of the primary transcript of RNA molecules, than any other organisms. Much editing is done in the nervous system, particularly for excitability and neuronal morphology. Coleoids rely mostly on ADAR enzymes for RNA editing, which requires large, double-stranded RNA structures. The many editing sites are conserved in the coleoid genome and the mutation rates for the sites are hampered. Hence, greater transcriptome plasticity has come at the cost of slower genome evolution. The genome of octopuses has also gone through several chromosomal fusions and rearrangements, unlike that of their closest relative the vampire squid, whose chromosomal structure is more basal and squid-like. The octopus genome is unremarkably bilaterian except for large developments of two gene families: protocadherins, which regulate the development of neurons; and the C2H2 zinc-finger transcription factors. Many novel genes in both cephalopods generally and octopus specifically manifest in the animals' skin, suckers, and nervous system.
Sources: en.wikipedia.org
No. Epithalamin is a peptide-containing extract of bovine pineal glands, while epitalon is a single synthetic tetrapeptide. The extract contains many peptides and other tissue components, so its composition varies between batches in ways that a synthesised sequence does not.
It is not recognised as an endogenous peptide hormone. The four-residue sequence can appear inside larger proteins and in digestive fragments of dietary protein, but no dedicated pathway producing it as a signalling molecule has been identified.
Several cell-culture reports describe increased telomerase activity after treatment, measured by enzyme assays or by transcript levels. Results differ between cell types and laboratories, and measured telomere lengthening has been reported in some studies but not in others, which leaves the physiological relevance open.
It is a synthetic tetrapeptide built from alanine, glutamate, aspartate and glycine. The four residues are joined by standard peptide bonds, giving a linear chain rather than a branched structure.